Get started
Author

Quande Lin

Observed names: Lin, Quande, Q D Lin, Q Lin, Q. Lin, QUANDE LIN, Quan-De Lin, Quan-de Lin, Quan‐De Lin, Quan‐de Lin, quande Lin
Observed institutions: Henan University, Zhengzhou University, Henan Cancer Hospital, Sun Yat-sen University Cancer Center, First Affiliated Hospital of Zhengzhou University, Qilu Pharmaceutical Co., Ltd. (China)
ORCID: 0000-0002-8460-4674
Observed ORCID: 0000-0002-8460-4674
OpenAlex ID: A5103277751
Universal CARs, universal T cells, and universal CAR T cells
2018 · Juanjuan Zhao, Quande Lin, et al. · Journal of Hematology & Oncology · 310
PDF
Human adipose tissue‐derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft‐vs.‐host disease in two children
2007 · Baijun Fang, Yongping Song, et al. · Pediatric Transplantation · 122
Recent updates on CAR T clinical trials for multiple myeloma
2019 · Quande Lin, Juanjuan Zhao, et al. · Molecular Cancer · 99
PDF
Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade
2020 · Yan Wang, Quande Lin, et al. · Cancer Cell International · 53
PDF
Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis
2020 · Yan Wang, Quande Lin, et al. · Cell Cycle · 38
PDF
The impact of gut microbial signals on hematopoietic stem cells and the bone marrow microenvironment
2024 · Xiru Liu, Hao Zhang, et al. · Frontiers in Immunology · 24
PDF
Primary skeletal muscle diffuse large B cell lymphoma: A case report and review of the literature
2015 · LIJUAN ZHANG, QUANDE LIN, et al. · Oncology Letters · 24
PDF
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
2019 · Quande Lin, Xiyang Liu, et al. · Bone Marrow Transplantation · 23
PDF
LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15
2020 · Wenli Zuo, Keshu Zhou, et al. · Aging · 21
Optimizing CAR-T cell Culture: Differential effects of IL-2, IL-12, and IL-21 on CAR-T cells
2024 · Mengmeng Zhang, JingJing Kong, et al. · Cytokine · 19
Exosome‐Mediated Lectin Pathway and Resistin‐MIF‐AA Metabolism Axis Drive Immune Dysfunction in Immune Thrombocytopenia
2025 · Jin Li, Xiaoqian Wang, et al. · Advanced Science · 16
PDF
Molecular glue degrader for tumor treatment
2024 · Yuhan Hu, Yan Yan, et al. · Frontiers in Oncology · 16
Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting
2023 · Jiangxue Hou, Yufu Li, et al. · Experimental Hematology and Oncology · 15
PDF
Efficacy of bortezomib and thalidomide in the recrudescent form of multicentric mixed-type Castleman's disease
2015 · Q Lin, B Fang, et al. · Blood Cancer Journal · 12
PDF
Human Adipose Tissue–Derived Adult Stem Cells Can Lead to Multiorgan Engraftment
2010 · B. Fang, Y. Li, et al. · Transplantation Proceedings · 11
Mechanisms of resistance to CAR-T cell therapy in multiple myeloma: latest updates from the 2024 ASH annual meeting
2025 · Yuhan Hu, Jiangxue Hou, et al. · Experimental Hematology and Oncology · 10
Comparison of human post-embryonic, multipotent stem cells derived from various tissues
2009 · Baijun Fang, Ning Li, et al. · Biotechnology Letters · 10
Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma
2017 · Wenli Zuo, Xinghu Zhu, et al. · Medicine · 9
Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib
2007 · Baijun Fang, Yongping Song, et al. · Leukemia Research · 9
Targeted single‐cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis‐resistant state in hematologic malignancies
2023 · Xiaohui Shen, Peiyuan Dong, et al. · Cell Biochemistry and Function · 8
The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma
2019 · Pu Xiang, Yuzhang Liu, et al. · Acta Haematologica · 7
Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting
2025 · Qing Zhang, Yongping Song, et al. · Biomarker Research · 6
PDF
Treatment of Epstein–Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion
2018 · Juanjuan Zhao, Yingling Zu, et al. · Bone Marrow Transplantation · 6
Hsa_circ_0111738 Inhibits Tumor Progression and Angiogenesis in Multiple Myeloma by Sponging miR-1233-3p to Regulate HIF-1 Signaling Pathway
2023 · Ping Wang, Yanli Zhang, et al. · Archives of Medical Research · 5
Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods
2019 · Hong-Mei Zhang, Xi-Yang Liu, et al. · Cancer Management and Research · 5
PDF
Works count: 81
Citation count: 919
H-index: 13
I10-index: 17
Year
Topic
Type